{
 "drug": "Hydromorphone Hydrochloride Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "10/31/2017",
 "dayN": 3220,
 "cat": "Analgesia/Addiction",
 "companies": [
  "Hospira, Inc., a Pfizer Company",
  "Hikma Pharmaceuticals USA, Inc.",
  "Teva Pharmaceuticals USA, Inc.",
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [
  "Other",
  "Demand increase for the drug"
 ],
 "records": [
  {
   "update_type": "Revised",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-1283-37",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "NDA200403"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1283",
     "0409-1312",
     "0409-4264",
     "0409-1805",
     "0409-2552",
     "0409-3356",
     "0409-2540",
     "0409-3365",
     "0409-1304"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897756",
     "897757",
     "1433251",
     "1724383",
     "1724644",
     "2675350",
     "897653",
     "897753",
     "897758",
     "1724276"
    ],
    "spl_id": [
     "766e302a-2d03-4d93-b237-2348b57ee517",
     "a3ebafac-648e-47b1-a6f5-1e3bff1e3e08"
    ],
    "spl_set_id": [
     "f9ca2ef5-46d8-475a-a26e-f7c8becd6db7",
     "e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"
    ],
    "package_ndc": [
     "0409-1283-17",
     "0409-1283-37",
     "0409-1312-16",
     "0409-1312-36",
     "0409-4264-11",
     "0409-4264-01",
     "0409-1805-10",
     "0409-1805-01",
     "0409-2552-11",
     "0409-2552-01",
     "0409-3356-11",
     "0409-3356-01",
     "0409-2540-11",
     "0409-2540-01",
     "0409-3365-11",
     "0409-3365-01",
     "0409-3365-10",
     "0409-1283-03",
     "0409-1283-31",
     "0409-1312-03",
     "0409-1312-30",
     "0409-1304-03",
     "0409-1304-31"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-1312-36",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA200403"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1312",
     "0409-1283",
     "0409-4264",
     "0409-1805",
     "0409-2552",
     "0409-3356",
     "0409-2540",
     "0409-3365",
     "0409-1304"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897756",
     "897757",
     "1433251",
     "1724383",
     "1724644",
     "2675350",
     "897653",
     "897753",
     "897758",
     "1724276"
    ],
    "spl_id": [
     "766e302a-2d03-4d93-b237-2348b57ee517",
     "a3ebafac-648e-47b1-a6f5-1e3bff1e3e08"
    ],
    "spl_set_id": [
     "f9ca2ef5-46d8-475a-a26e-f7c8becd6db7",
     "e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"
    ],
    "package_ndc": [
     "0409-1283-17",
     "0409-1283-37",
     "0409-1312-16",
     "0409-1312-36",
     "0409-4264-11",
     "0409-4264-01",
     "0409-1805-10",
     "0409-1805-01",
     "0409-2552-11",
     "0409-2552-01",
     "0409-3356-11",
     "0409-3356-01",
     "0409-2540-11",
     "0409-2540-01",
     "0409-3365-11",
     "0409-3365-01",
     "0409-3365-10",
     "0409-1283-03",
     "0409-1283-31",
     "0409-1312-03",
     "0409-1312-30",
     "0409-1304-03",
     "0409-1304-31"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/01/2017",
   "package_ndc": "0409-4264-01",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Limited Availability",
   "related_info": "Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "NDA200403"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-4264",
     "0409-1283",
     "0409-1312",
     "0409-1805"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897756",
     "897757",
     "1433251",
     "1724383",
     "1724644",
     "2675350"
    ],
    "spl_id": [
     "766e302a-2d03-4d93-b237-2348b57ee517"
    ],
    "spl_set_id": [
     "f9ca2ef5-46d8-475a-a26e-f7c8becd6db7"
    ],
    "package_ndc": [
     "0409-1283-17",
     "0409-1283-37",
     "0409-1312-16",
     "0409-1312-36",
     "0409-4264-11",
     "0409-4264-01",
     "0409-1805-10",
     "0409-1805-01"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "change_date": "01/02/2025",
   "package_ndc": "0409-1283-31",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA200403"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1283",
     "0409-1312",
     "0409-4264",
     "0409-1805",
     "0409-2552",
     "0409-3356",
     "0409-2540",
     "0409-3365",
     "0409-1304"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897756",
     "897757",
     "1433251",
     "1724383",
     "1724644",
     "2675350",
     "897653",
     "897753",
     "897758",
     "1724276"
    ],
    "spl_id": [
     "766e302a-2d03-4d93-b237-2348b57ee517",
     "a3ebafac-648e-47b1-a6f5-1e3bff1e3e08"
    ],
    "spl_set_id": [
     "f9ca2ef5-46d8-475a-a26e-f7c8becd6db7",
     "e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"
    ],
    "package_ndc": [
     "0409-1283-17",
     "0409-1283-37",
     "0409-1312-16",
     "0409-1312-36",
     "0409-4264-11",
     "0409-4264-01",
     "0409-1805-10",
     "0409-1805-01",
     "0409-2552-11",
     "0409-2552-01",
     "0409-3356-11",
     "0409-3356-01",
     "0409-2540-11",
     "0409-2540-01",
     "0409-3365-11",
     "0409-3365-01",
     "0409-3365-10",
     "0409-1283-03",
     "0409-1283-31",
     "0409-1312-03",
     "0409-1312-30",
     "0409-1304-03",
     "0409-1304-31"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/01/2017",
   "package_ndc": "0641-6254-01",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Product temporarily on backorder.  Additional lots will be available in the August 2026 timeframe.",
   "openfda": {
    "application_number": [
     "NDA217812"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6254"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897745"
    ],
    "spl_id": [
     "ba25ec4f-3b81-4960-bf74-6a1e4c6be45c"
    ],
    "spl_set_id": [
     "c729424e-e483-4bf8-b86c-ce56636dcffa"
    ],
    "package_ndc": [
     "0641-6254-01"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-2634-05",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA078591"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2634"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1724338",
     "1724340",
     "1724341"
    ],
    "spl_id": [
     "50886ad5-eeca-4fe7-beb0-01305f92c65d"
    ],
    "spl_set_id": [
     "3832ede8-d3fc-455d-ecab-3b77be5869f5"
    ],
    "package_ndc": [
     "0409-2634-10",
     "0409-2634-01",
     "0409-2634-25",
     "0409-2634-05",
     "0409-2634-50"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "change_date": "01/02/2025",
   "package_ndc": "0409-1312-30",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA200403"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1312",
     "0409-1283",
     "0409-4264",
     "0409-1805",
     "0409-2552",
     "0409-3356",
     "0409-2540",
     "0409-3365",
     "0409-1304"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897756",
     "897757",
     "1433251",
     "1724383",
     "1724644",
     "2675350",
     "897653",
     "897753",
     "897758",
     "1724276"
    ],
    "spl_id": [
     "766e302a-2d03-4d93-b237-2348b57ee517",
     "a3ebafac-648e-47b1-a6f5-1e3bff1e3e08"
    ],
    "spl_set_id": [
     "f9ca2ef5-46d8-475a-a26e-f7c8becd6db7",
     "e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"
    ],
    "package_ndc": [
     "0409-1283-17",
     "0409-1283-37",
     "0409-1312-16",
     "0409-1312-36",
     "0409-4264-11",
     "0409-4264-01",
     "0409-1805-10",
     "0409-1805-01",
     "0409-2552-11",
     "0409-2552-01",
     "0409-3356-11",
     "0409-3356-01",
     "0409-2540-11",
     "0409-2540-01",
     "0409-3365-11",
     "0409-3365-01",
     "0409-3365-10",
     "0409-1283-03",
     "0409-1283-31",
     "0409-1312-03",
     "0409-1312-30",
     "0409-1304-03",
     "0409-1304-31"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-1304-31",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA200403"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1304",
     "0409-2552",
     "0409-3356",
     "0409-2540",
     "0409-3365",
     "0409-1283",
     "0409-1312"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897653",
     "897753",
     "897756",
     "897757",
     "897758",
     "1724276",
     "1724383",
     "1724644"
    ],
    "spl_id": [
     "a3ebafac-648e-47b1-a6f5-1e3bff1e3e08"
    ],
    "spl_set_id": [
     "e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"
    ],
    "package_ndc": [
     "0409-2552-11",
     "0409-2552-01",
     "0409-3356-11",
     "0409-3356-01",
     "0409-2540-11",
     "0409-2540-01",
     "0409-3365-11",
     "0409-3365-01",
     "0409-3365-10",
     "0409-1283-03",
     "0409-1283-31",
     "0409-1312-03",
     "0409-1312-30",
     "0409-1304-03",
     "0409-1304-31"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/01/2017",
   "package_ndc": "0703-0110-03",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "800-545-8800",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA078591"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Teva Parenteral Medicines, Inc."
    ],
    "product_ndc": [
     "0703-0110",
     "0703-0113",
     "0703-0018"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1724338",
     "1724340",
     "1724341"
    ],
    "spl_id": [
     "540b835a-db66-417c-8507-0c1ed05c95bf"
    ],
    "spl_set_id": [
     "f0b78db9-a38c-41bb-8233-5e93f7f18c5c"
    ],
    "package_ndc": [
     "0703-0110-01",
     "0703-0110-03",
     "0703-0113-01",
     "0703-0113-03",
     "0703-0018-01"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "76045-009-11",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Next release September 2026. Check wholesalers for inventory.",
   "openfda": {
    "application_number": [
     "NDA019034"
    ],
    "brand_name": [
     "DILAUDID"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "76045-009",
     "76045-010",
     "76045-121"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897756",
     "897757",
     "1433251",
     "1872265",
     "1872269",
     "1872752",
     "2277368",
     "2277370"
    ],
    "spl_id": [
     "97bfcafb-2037-47dc-a0ae-f7b8007c47df"
    ],
    "spl_set_id": [
     "9eebd88a-5632-460f-b7b6-26c8a180540d"
    ],
    "package_ndc": [
     "76045-009-96",
     "76045-009-06",
     "76045-009-01",
     "76045-009-11",
     "76045-010-01",
     "76045-010-11",
     "76045-121-01",
     "76045-121-11"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "63323-852-25",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "NDA019034"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-852",
     "63323-851",
     "63323-853",
     "63323-854"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897653",
     "897753",
     "1724276",
     "1724338",
     "1724340",
     "1724341"
    ],
    "spl_id": [
     "9e8522c6-595c-46f9-bb25-272aa4683e0f"
    ],
    "spl_set_id": [
     "e034eb96-03e0-46e1-8b92-5e1f94555e7b"
    ],
    "package_ndc": [
     "63323-851-03",
     "63323-851-10",
     "63323-851-07",
     "63323-851-15",
     "63323-851-50",
     "63323-852-03",
     "63323-852-25",
     "63323-853-03",
     "63323-853-25",
     "63323-854-03",
     "63323-854-10"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/01/2017",
   "package_ndc": "0703-0018-01",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "800-545-8800",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA078591"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Teva Parenteral Medicines, Inc."
    ],
    "product_ndc": [
     "0703-0018",
     "0703-0110",
     "0703-0113"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1724338",
     "1724340",
     "1724341"
    ],
    "spl_id": [
     "540b835a-db66-417c-8507-0c1ed05c95bf"
    ],
    "spl_set_id": [
     "f0b78db9-a38c-41bb-8233-5e93f7f18c5c"
    ],
    "package_ndc": [
     "0703-0110-01",
     "0703-0110-03",
     "0703-0113-01",
     "0703-0113-03",
     "0703-0018-01"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/01/2017",
   "package_ndc": "63323-854-10",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "NDA019034"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-854",
     "63323-851",
     "63323-852",
     "63323-853"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897653",
     "897753",
     "1724276",
     "1724338",
     "1724340",
     "1724341"
    ],
    "spl_id": [
     "9e8522c6-595c-46f9-bb25-272aa4683e0f"
    ],
    "spl_set_id": [
     "e034eb96-03e0-46e1-8b92-5e1f94555e7b"
    ],
    "package_ndc": [
     "63323-851-03",
     "63323-851-10",
     "63323-851-07",
     "63323-851-15",
     "63323-851-50",
     "63323-852-03",
     "63323-852-25",
     "63323-853-03",
     "63323-853-25",
     "63323-854-03",
     "63323-854-10"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-2634-01",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA078591"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2634"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1724338",
     "1724340",
     "1724341"
    ],
    "spl_id": [
     "50886ad5-eeca-4fe7-beb0-01305f92c65d"
    ],
    "spl_set_id": [
     "3832ede8-d3fc-455d-ecab-3b77be5869f5"
    ],
    "package_ndc": [
     "0409-2634-10",
     "0409-2634-01",
     "0409-2634-25",
     "0409-2634-05",
     "0409-2634-50"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-2634-50",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA078591"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-2634"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1724338",
     "1724340",
     "1724341"
    ],
    "spl_id": [
     "50886ad5-eeca-4fe7-beb0-01305f92c65d"
    ],
    "spl_set_id": [
     "3832ede8-d3fc-455d-ecab-3b77be5869f5"
    ],
    "package_ndc": [
     "0409-2634-10",
     "0409-2634-01",
     "0409-2634-25",
     "0409-2634-05",
     "0409-2634-50"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/01/2017",
   "package_ndc": "0703-0113-03",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "800-545-8800",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA078591"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Teva Parenteral Medicines, Inc."
    ],
    "product_ndc": [
     "0703-0113",
     "0703-0110",
     "0703-0018"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1724338",
     "1724340",
     "1724341"
    ],
    "spl_id": [
     "540b835a-db66-417c-8507-0c1ed05c95bf"
    ],
    "spl_set_id": [
     "f0b78db9-a38c-41bb-8233-5e93f7f18c5c"
    ],
    "package_ndc": [
     "0703-0110-01",
     "0703-0110-03",
     "0703-0113-01",
     "0703-0113-03",
     "0703-0018-01"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "11/01/2017",
   "package_ndc": "0409-1805-01",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "NDA200403"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1805",
     "0409-1283",
     "0409-1312",
     "0409-4264"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897756",
     "897757",
     "1433251",
     "1724383",
     "1724644",
     "2675350"
    ],
    "spl_id": [
     "766e302a-2d03-4d93-b237-2348b57ee517"
    ],
    "spl_set_id": [
     "f9ca2ef5-46d8-475a-a26e-f7c8becd6db7"
    ],
    "package_ndc": [
     "0409-1283-17",
     "0409-1283-37",
     "0409-1312-16",
     "0409-1312-36",
     "0409-4264-11",
     "0409-4264-01",
     "0409-1805-10",
     "0409-1805-01"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "63323-851-10",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "NDA019034"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-851",
     "63323-852",
     "63323-853",
     "63323-854"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897653",
     "897753",
     "1724276",
     "1724338",
     "1724340",
     "1724341"
    ],
    "spl_id": [
     "9e8522c6-595c-46f9-bb25-272aa4683e0f"
    ],
    "spl_set_id": [
     "e034eb96-03e0-46e1-8b92-5e1f94555e7b"
    ],
    "package_ndc": [
     "63323-851-03",
     "63323-851-10",
     "63323-851-07",
     "63323-851-15",
     "63323-851-50",
     "63323-852-03",
     "63323-852-25",
     "63323-853-03",
     "63323-853-25",
     "63323-854-03",
     "63323-854-10"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-3365-10",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA200403"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-3365",
     "0409-2552",
     "0409-3356",
     "0409-2540",
     "0409-1283",
     "0409-1312",
     "0409-1304"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897653",
     "897753",
     "897756",
     "897757",
     "897758",
     "1724276",
     "1724383",
     "1724644"
    ],
    "spl_id": [
     "a3ebafac-648e-47b1-a6f5-1e3bff1e3e08"
    ],
    "spl_set_id": [
     "e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"
    ],
    "package_ndc": [
     "0409-2552-11",
     "0409-2552-01",
     "0409-3356-11",
     "0409-3356-01",
     "0409-2540-11",
     "0409-2540-01",
     "0409-3365-11",
     "0409-3365-01",
     "0409-3365-10",
     "0409-1283-03",
     "0409-1283-31",
     "0409-1312-03",
     "0409-1312-30",
     "0409-1304-03",
     "0409-1304-31"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/01/2017",
   "package_ndc": "76045-121-11",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "NDA019034"
    ],
    "brand_name": [
     "DILAUDID"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "76045-121",
     "76045-009",
     "76045-010"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897756",
     "897757",
     "1433251",
     "1872265",
     "1872269",
     "1872752",
     "2277368",
     "2277370"
    ],
    "spl_id": [
     "97bfcafb-2037-47dc-a0ae-f7b8007c47df"
    ],
    "spl_set_id": [
     "9eebd88a-5632-460f-b7b6-26c8a180540d"
    ],
    "package_ndc": [
     "76045-009-96",
     "76045-009-06",
     "76045-009-01",
     "76045-009-11",
     "76045-010-01",
     "76045-010-11",
     "76045-121-01",
     "76045-121-11"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "76045-009-06",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Next release August 2026. Check wholesalers for inventory.",
   "openfda": {
    "application_number": [
     "NDA019034"
    ],
    "brand_name": [
     "DILAUDID"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "76045-009",
     "76045-010",
     "76045-121"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897756",
     "897757",
     "1433251",
     "1872265",
     "1872269",
     "1872752",
     "2277368",
     "2277370"
    ],
    "spl_id": [
     "97bfcafb-2037-47dc-a0ae-f7b8007c47df"
    ],
    "spl_set_id": [
     "9eebd88a-5632-460f-b7b6-26c8a180540d"
    ],
    "package_ndc": [
     "76045-009-96",
     "76045-009-06",
     "76045-009-01",
     "76045-009-11",
     "76045-010-01",
     "76045-010-11",
     "76045-121-01",
     "76045-121-11"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "63323-853-25",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "NDA019034"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-853",
     "63323-851",
     "63323-852",
     "63323-854"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897653",
     "897753",
     "1724276",
     "1724338",
     "1724340",
     "1724341"
    ],
    "spl_id": [
     "9e8522c6-595c-46f9-bb25-272aa4683e0f"
    ],
    "spl_set_id": [
     "e034eb96-03e0-46e1-8b92-5e1f94555e7b"
    ],
    "package_ndc": [
     "63323-851-03",
     "63323-851-10",
     "63323-851-07",
     "63323-851-15",
     "63323-851-50",
     "63323-852-03",
     "63323-852-25",
     "63323-853-03",
     "63323-853-25",
     "63323-854-03",
     "63323-854-10"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/03/2017",
   "change_date": "01/03/2025",
   "package_ndc": "0641-0121-25",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.",
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/01/2017",
   "package_ndc": "76045-010-11",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Next release not available at this time.  Check wholesalers for inventory.",
   "openfda": {
    "application_number": [
     "NDA019034"
    ],
    "brand_name": [
     "DILAUDID"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "76045-010",
     "76045-009",
     "76045-121"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897756",
     "897757",
     "1433251",
     "1872265",
     "1872269",
     "1872752",
     "2277368",
     "2277370"
    ],
    "spl_id": [
     "97bfcafb-2037-47dc-a0ae-f7b8007c47df"
    ],
    "spl_set_id": [
     "9eebd88a-5632-460f-b7b6-26c8a180540d"
    ],
    "package_ndc": [
     "76045-009-96",
     "76045-009-06",
     "76045-009-01",
     "76045-009-11",
     "76045-010-01",
     "76045-010-11",
     "76045-121-01",
     "76045-121-11"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "63323-851-50",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "NDA019034"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-851",
     "63323-852",
     "63323-853",
     "63323-854"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897653",
     "897753",
     "1724276",
     "1724338",
     "1724340",
     "1724341"
    ],
    "spl_id": [
     "9e8522c6-595c-46f9-bb25-272aa4683e0f"
    ],
    "spl_set_id": [
     "e034eb96-03e0-46e1-8b92-5e1f94555e7b"
    ],
    "package_ndc": [
     "63323-851-03",
     "63323-851-10",
     "63323-851-07",
     "63323-851-15",
     "63323-851-50",
     "63323-852-03",
     "63323-852-25",
     "63323-853-03",
     "63323-853-25",
     "63323-854-03",
     "63323-854-10"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "63323-851-15",
   "generic_name": "Hydromorphone Hydrochloride Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Next release August 2026. Check wholesalers for inventory.",
   "openfda": {
    "application_number": [
     "NDA019034"
    ],
    "brand_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "generic_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-851",
     "63323-852",
     "63323-853",
     "63323-854"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "HYDROMORPHONE HYDROCHLORIDE"
    ],
    "rxcui": [
     "897653",
     "897753",
     "1724276",
     "1724338",
     "1724340",
     "1724341"
    ],
    "spl_id": [
     "9e8522c6-595c-46f9-bb25-272aa4683e0f"
    ],
    "spl_set_id": [
     "e034eb96-03e0-46e1-8b92-5e1f94555e7b"
    ],
    "package_ndc": [
     "63323-851-03",
     "63323-851-10",
     "63323-851-07",
     "63323-851-15",
     "63323-851-50",
     "63323-852-03",
     "63323-852-25",
     "63323-853-03",
     "63323-853-25",
     "63323-854-03",
     "63323-854-10"
    ],
    "unii": [
     "L960UP2KRW"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Other",
   "status": "Current"
  }
 ]
}